Position in ABT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$53,885,495
-$8,847,517 QoQ
Shares Held
593,845
-2.8% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#215
of 2,966 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026BRADLEY FOSTER & SARGENT INC/CT holds $87,877,885 across 9 Medical Devices names. ABT ranks #1 (61.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
This page
|
593,845 | $53,885,495 | |
| 2 | SYK |
Stryker Corp
|
63,139 | $19,878,682 | |
| 3 | GEHC |
GE HealthCare Technologies Inc.
|
84,197 | $5,389,449 | |
| 4 | BSX |
Boston Scientific Corp
|
69,510 | $2,966,686 | |
| 5 | MDT |
Medtronic plc
|
29,052 | $2,272,737 | |
| 6 | EW |
Edwards Lifesciences Corp
|
14,372 | $1,300,091 | |
| 7 | AXGN |
Axogen, Inc.
|
24,577 | $1,135,211 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
6,250 | $538,062 |
All Filings in ABT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,885,495 | 593,845 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $62,733,012 | 611,016 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $104,601,614 | 834,876 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $111,278,959 | 830,812 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $112,795,405 | 829,317 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $103,155,670 | 777,653 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $71,910,021 | 635,753 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $68,443,623 | 600,330 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $52,870,654 | 508,812 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $52,857,355 | 465,048 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $49,808,876 | 452,520 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $41,070,307 | 424,061 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $46,231,130 | 424,061 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $35,120,917 | 346,839 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $38,146,645 | 347,451 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $33,394,488 | 345,127 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $37,685,143 | 346,849 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $41,422,330 | 349,969 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $48,235,960 | 342,731 | Shares | Sole | 2022-03-11 | |
| 2021-09-30 | $39,050,942 | 330,576 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $39,144,228 | 337,654 | Shares | Sole | 2021-08-19 | |
| 2021-03-31 | $40,775,919 | 340,253 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $38,640,882 | 352,917 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $38,425,805 | 353,081 | Shares | Sole | 2020-10-26 | |
| 2020-03-31 | $28,563,920 | 361,981 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||